ZA200409624B - Pharmaceutical salts of reboxetine - Google Patents

Pharmaceutical salts of reboxetine

Info

Publication number: ZA200409624B
Authority: ZA; South Africa
Prior art keywords: reboxetine; pharmaceutical salts; pharmaceutical; salts
Prior art date: 2002-06-17

Application number

ZA200409624A

Other languages

English (en)

Inventor

Massimo Zampieri

Annalisa Airoldi

Alessandro Martini

Original Assignee

Pharmacia Italia Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-17

Filing date

2004-11-29

Publication date

2006-05-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29724495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200409624(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-11-29 Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa

2006-05-31 Publication of ZA200409624B publication Critical patent/ZA200409624B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Addiction (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Toxicology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA200409624A 2002-06-17 2004-11-29 Pharmaceutical salts of reboxetine ZA200409624B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02077366		2002-06-17

Publications (1)

Publication Number	Publication Date
ZA200409624B true ZA200409624B (en)	2006-05-31

Family

ID=29724495

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200409624A ZA200409624B (en)	2002-06-17	2004-11-29	Pharmaceutical salts of reboxetine

Country Status (23)

Country	Link
US (2)	US20070010517A1 (xx)
EP (1)	EP1515959B1 (xx)
JP (1)	JP4563172B2 (xx)
KR (1)	KR100779786B1 (xx)
CN (2)	CN101298440A (xx)
AR (1)	AR040222A1 (xx)
AT (1)	ATE439354T1 (xx)
AU (1)	AU2003227755B2 (xx)
BR (1)	BR0311878A (xx)
CA (1)	CA2489763C (xx)
DE (1)	DE60328787D1 (xx)
DK (1)	DK1515959T3 (xx)
ES (1)	ES2328472T3 (xx)
MX (1)	MXPA04011916A (xx)
MY (1)	MY131231A (xx)
NO (1)	NO329346B1 (xx)
NZ (1)	NZ537023A (xx)
PE (1)	PE20040565A1 (xx)
PL (1)	PL375211A1 (xx)
RU (1)	RU2286341C2 (xx)
TW (1)	TWI267510B (xx)
WO (1)	WO2003106441A1 (xx)
ZA (1)	ZA200409624B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0319793D0 (en) *	2003-08-22	2003-09-24	Lilly Co Eli	Pyridinylmorpholine derivatives
WO2005082869A1 (en) *	2004-02-20	2005-09-09	Pharmacia & Upjohn Company Llc	Method for the preparation of aryl ethers
US8580776B2 (en) *	2007-07-10	2013-11-12	The Board Of Trustees Of The University Of Illinois	Compositions and methods for treating neurodegenerating diseases
US20100069389A1 (en) *	2008-09-06	2010-03-18	Bionevia Pharmaceuticals, Inc.	Novel forms of reboxetine
US20190185438A1 (en) *	2016-12-06	2019-06-20	Tonix Pharmaceuticals Holding Corp.	Salts and polymorphs of esreboxetine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2167407B (en) *	1984-11-22	1988-05-11	Erba Farmitalia	Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
UA56257C2 (uk) *	1997-09-23	2003-05-15	Елі Ліллі Енд Компані	Спосіб лікування неадекватної визивної поведінки
UA57107C2 (uk) *	1997-09-23	2003-06-16	Елі Ліллі Енд Компані	Спосіб лікування розладу поведінки
CA2304112A1 (en) *	1997-09-23	1999-04-01	John Harrison Heiligenstein	Treatment of attention-deficit/hyperactivity disorder
IT1305322B1 (it) *	1998-04-23	2001-05-04	Pharmacia & Upjohn Spa	Uso di reboxetina per il trattamento di disturbi nervosi
PL196996B1 (pl) *	1999-07-01	2008-02-29	Upjohn Co	Zastosowanie optycznie czystej (S,S)-reboksetyny lub jej dopuszczalnej farmaceutycznie soli do wytwarzania leku

2003
- 2003-06-04 US US10/588,808 patent/US20070010517A1/en not_active Abandoned
- 2003-06-04 CN CNA200810093308XA patent/CN101298440A/zh active Pending
- 2003-06-04 DE DE60328787T patent/DE60328787D1/de not_active Expired - Lifetime
- 2003-06-04 PL PL03375211A patent/PL375211A1/xx not_active Application Discontinuation
- 2003-06-04 MX MXPA04011916A patent/MXPA04011916A/es active IP Right Grant
- 2003-06-04 RU RU2005100846/04A patent/RU2286341C2/ru not_active IP Right Cessation
- 2003-06-04 BR BR0311878-9A patent/BR0311878A/pt not_active IP Right Cessation
- 2003-06-04 NZ NZ537023A patent/NZ537023A/en unknown
- 2003-06-04 CA CA002489763A patent/CA2489763C/en not_active Expired - Fee Related
- 2003-06-04 AU AU2003227755A patent/AU2003227755B2/en not_active Ceased
- 2003-06-04 WO PCT/EP2003/005261 patent/WO2003106441A1/en not_active Ceased
- 2003-06-04 ES ES03725195T patent/ES2328472T3/es not_active Expired - Lifetime
- 2003-06-04 DK DK03725195T patent/DK1515959T3/da active
- 2003-06-04 CN CN038139839A patent/CN1662511B/zh not_active Expired - Fee Related
- 2003-06-04 KR KR1020047020412A patent/KR100779786B1/ko not_active Expired - Fee Related
- 2003-06-04 EP EP03725195A patent/EP1515959B1/en not_active Expired - Lifetime
- 2003-06-04 JP JP2004513273A patent/JP4563172B2/ja not_active Expired - Fee Related
- 2003-06-04 AT AT03725195T patent/ATE439354T1/de not_active IP Right Cessation
- 2003-06-11 MY MYPI20032183A patent/MY131231A/en unknown
- 2003-06-11 TW TW092115889A patent/TWI267510B/zh not_active IP Right Cessation
- 2003-06-13 AR ARP030102115A patent/AR040222A1/es unknown
- 2003-06-17 PE PE2003000594A patent/PE20040565A1/es not_active Application Discontinuation
2004
- 2004-11-29 ZA ZA200409624A patent/ZA200409624B/xx unknown
2005
- 2005-01-12 NO NO20050183A patent/NO329346B1/no not_active IP Right Cessation
2009
- 2009-05-21 US US12/469,780 patent/US20090291953A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO329346B1 (no)	2010-10-04
AR040222A1 (es)	2005-03-16
EP1515959B1 (en)	2009-08-12
KR20050019137A (ko)	2005-02-28
CN1662511A (zh)	2005-08-31
AU2003227755A1 (en)	2003-12-31
AU2003227755B2 (en)	2009-01-15
NZ537023A (en)	2006-09-29
WO2003106441A1 (en)	2003-12-24
CA2489763C (en)	2007-12-18
JP4563172B2 (ja)	2010-10-13
HK1077572A1 (zh)	2006-02-17
US20090291953A1 (en)	2009-11-26
DK1515959T3 (da)	2009-11-02
RU2286341C2 (ru)	2006-10-27
KR100779786B1 (ko)	2007-11-28
MY131231A (en)	2007-07-31
CA2489763A1 (en)	2003-12-24
MXPA04011916A (es)	2005-03-31
BR0311878A (pt)	2005-04-05
EP1515959A1 (en)	2005-03-23
RU2005100846A (ru)	2005-06-10
JP2005533791A (ja)	2005-11-10
CN101298440A (zh)	2008-11-05
US20070010517A1 (en)	2007-01-11
NO20050183L (no)	2005-01-12
ATE439354T1 (de)	2009-08-15
TW200403230A (en)	2004-03-01
ES2328472T3 (es)	2009-11-13
PL375211A1 (en)	2005-11-28
PE20040565A1 (es)	2004-09-02
CN1662511B (zh)	2010-06-09
TWI267510B (en)	2006-12-01
DE60328787D1 (de)	2009-09-24

Publication	Publication Date	Title
SI1390023T1 (sl)	2008-10-31	Farmacevtske soli spojin 1-fenil-3-dimetilamino-propana
AU2003244650A8 (en)	2004-03-03	Medicinal compounds
GB0225540D0 (en)	2002-12-11	Medicinal compounds
GB0204719D0 (en)	2002-04-17	Medicinal compounds
GB0225535D0 (en)	2002-12-11	Medicinal compounds
GB0220730D0 (en)	2002-10-16	Medicinal compounds
GB0225030D0 (en)	2002-12-04	Medicinal compounds
PL377495A1 (pl)	2006-02-06	Stały lek do stosowania doustnego
HRP20050429A2 (en)	2005-06-30	Dosage form of sodium ibuprofen
PL372773A1 (en)	2005-08-08	Oral administration of epothilones
AU2003276572A1 (en)	2004-06-15	Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
GB0202900D0 (en)	2002-03-27	Novel formulations of drugs
IL166337A0 (en)	2006-01-16	Oral administration of calctionin
GB0206505D0 (en)	2002-05-01	Pharmaceutical combination
ZA200409624B (en)	2006-05-31	Pharmaceutical salts of reboxetine
AU2003295846A8 (en)	2004-06-18	Pharmaceutical formulations of celcoxib
PL373409A1 (en)	2005-08-22	Pharmaceutical combination
GB0201520D0 (en)	2002-03-13	Pharmaceutical uses
PL355453A1 (en)	2004-02-23	Pharmaceutical agent
EP1491189A4 (en)	2007-08-08	ORAL PHARMACEUTICALS WITH DICLOFENAC SODIUM
GB0204683D0 (en)	2002-04-17	Pharmaceutical salts
GB0206708D0 (en)	2002-05-01	Pharmaceutical salts
GB0225702D0 (en)	2002-12-11	Oral formulation of moisutre-sensitive drugs
GB0220451D0 (en)	2002-10-09	Pharmaceutical use
HK1083584A (en)	2006-07-07	Pharmaceutical dosage forms of biguanide-sulfonylurea combinations